Hepatic Cancer clinical trials

Explore recruiting hepatic cancer clinical trials.

Recruiting hepatic cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hepatic Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

SOLARIS – A phase-II open-label study of pembrolizumab and lenvatinib in patients with advanced stage hepatocellular carcinoma who are refractory to atezolizumab and bevacizumab/ IO-based therapy

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase 1/2 Dose Determination and Dose Expansion Study of Cobolimab in Combination with Dostarlimab in Pediatric and Young Adult Participants with Newly Diagnosed and Relapsed/Refractory Tumors (POPSTAR)

Spain, France, Germany, Denmark, Italy, Czechia

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Hepatic Cancer trials by city

Hepatic Cancer in Toronto Hepatic Cancer in Vancouver Hepatic Cancer in Montreal Hepatic Cancer in Calgary Hepatic Cancer in Edmonton Hepatic Cancer in Ottawa Hepatic Cancer in Winnipeg Hepatic Cancer in Quebec City Hepatic Cancer in Hamilton Hepatic Cancer in Kitchener Hepatic Cancer in London Hepatic Cancer in Halifax Hepatic Cancer in New York Hepatic Cancer in Los Angeles Hepatic Cancer in Chicago Hepatic Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease